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Src-homology 3 is a small protein domain of about GO amino acid residues. It is probably made of p-sheets. SI-13 is prcscn~ in alarge number of 
eukaryotic proteins which arc involved in sigma’ A transduction, cell polnrizntion and membranc-cytoskcleton interactions. Here WC review its 
occurrence and discuss possible functions of this domain. 
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1. INTRODUCTION 
SH3 (Src homology region 3) is a small protein do- 
main containing about 60 amino acid residues. It was 
first identified as a conserved scqucnce in the N-termi- 
nal non-catalytic part of the SW protein tyrosine kinases 
[l]. Src-kinases participate in signal transduction Ddth- 
ways originating at the receptor tyrosine kinases, such 
as the platelet derived growth factor receptor 
(PDGFR). A number of other proteins which are in- 
volved in these pathivays, have also been shown to con- 
tain SH3 domains. These include phospholipase Cy [2], 
phosphatidyl inositol-3-kinase (PI-3 kinase, e.g. [3]) and 
the ~21”” GTPnse activating protein (GAP, [43). An- 
other common non-catalytic domain of about 100 or 
more amino acid residues in these proteins is called 
SH2. One of its functions is to bind to peptides contain- 
ing phosphotyrosine (see [S] and below). 
ated erythrocyte membrane protein [21], and in Dgl, a 
homologous protein in Drosophila [22]. A gene (scmS) 
involved in development of nematode vulva encodes a 
protein that has two SH3 domains 1231. 
SH3 is not exclusively characteristic cfsignalling pro- 
teins. Both in single-cell and higher eukaryotes SH3 is 
present in a very large group of proteins, among them 
families which are otherwise unrelated to each other. 
These include erythroid and non-erythroid a-spectrins 
[6,7], two unconventional myosins in Acattrltattzocba [S], 
the p47 and ~67 cytosolic activators of the human neu- 
trophil respiratory burst oxidase [9,10], and putative 
tt tinscriptional regulators Vav and Hs 1 (e.g. [ 11,121). In 
yeast, SH3 is found in proteins involved in morphogene- 
sis, such as Bern-l [13,14] and the actin-binding protein 
Abpl [l S,16], proteins involved in mating (Fusl 
[17,18]), and in regulation of ras activity (Cdc25 and 
Ste6 [19,20]). Recently an SH3 domain has also been 
found in a 55 kDa protein which is a major palmitoyl- 
So far the function of SH3 has remsineti unclear. 
Rodaway and co-workers [24] have drawn attention to 
the fact that most of the SH3-containing proteins are 
associated with membranes. They suggested that SH3 
may have a role in subcellular localization, probably 
through interaction with components of the cortical cy- 
toskeleton. Several ines of evidence suggest hat SH3 
is involved in establishing or regulating such protein- 
protein interactions which may often occur close to the 
plasma membrane. The presence of SH3 domains in 
proteins involved in morphogenesis and signal 
transduction clearly indicates uch a role. On the other 
hand, it has been shown that the SH2 domain of viral 
Src is essential for its association with detergent-insolu- 
ble cellular matrix [25]. It has also been suggested that 
SH3 might mediate membrane-cytoskelctal interaction 
by binding to actin [ 161 but no conclusive vidence sup- 
ports this idea. 
SH3 has no fixed topological position in proteins 
(Fig. I). It seems likely that the position of SH3 in a 
protein sequence is not important for its function. A 
function, such as binding to a target protein, is therefore 
entirely confined to this domain. 
Corrcspondcnce uddress: A. Musacchio and M. Saras~c, EMBL, Mcy- 
erhofstr. 1, D-6900 Heidelberg, Germany. Fax: (49) (6221) 387306. 
2. A SEQUENCE ALIGNMENT 
Figure 2 shows an alignment of SH3 sequences. The 
alignment is limited to about GO amino acid residues, 
which seem to constimte the SH3 core. This choice of 
domain boundaries is justified by two facts. First, the 
SH3 domain in Ste6 and the first SH3 domain in Nck 
are at the extreme N-terminus. Second, in Hsl, Abpl. 
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Fig. I, SH?. and SH3 domains inselected proteins. P13’Wp85 is a subunit of phosphatidylinositol-3’.kinasc. PLCy is phospholipase-Cy and GAP 
is ~21”” GTPase activating protein. Nck. Abl and Src are oncopenc products discussed in text. Sem5 is a protein involved in vulva1 development 
of c. &guns. 
pSO/85 (which a substrate of Src kinasc [26]), and in one 
Acarttlzurnoebu myosin-I SH3 is located precisely at the 
C-terminus (see Fig. 2). 
The highest degree of conservation within the SH3 
domain is localised at the N- and C-termini and in some 
parts of the central region. Some conserved residues 
form patterns which may help to define the secondary 
structure of the SH3 domain. This is especially evident 
in the central region of the sequence, where the patterns 
of hydrophobic and hydrophilic amino acids suggest 
formation of p-strands. Three &strands may corre- 
spond to residues 17-20, 25-30 and 35-42 (Fig. 2). 
These seem to be connected to loop regions, corre- 
sponding to amino acids 13-16, 21-24, and 31-34. The 
first and the latter show a low degree of conservation, 
while the second putative loop region is rather con- 
served and shows a preference for charged residues. The 
N-terminal residues 4, 6, 8 and 10 are all more highly 
conserved than the alternating residues 3, 5, 7 and 9, 
implying the presence of a long P-strand. Part of this 
stretch is especially conserved and forms the character- 
istic ALYDY motif of SH3. The C-terminal region has 
also a regular pattern of hydrophilic and hydrophobic 
amino acids, which may be compatible with formation 
of one or two further strands. 
Prediction of secondary structure can be assisted by 
the distribution of glycine and proline residues. Figure 
2 shows regions where glycine and proline are poorly 
tolerated and which may correspond to b-strands. 
Glycine residues are most often present in the putative 
loop regions. There are several conserved glycine posi- 
tions (23, 34, and 45 following the numbering in Fig. 2). 
G48 is almost invariant, together with P51. 
We suggest hat the SH3 do:nain foids into an all 
,&structure, with 5 or G strands connected by loops. 
Circular dichroic spectrum determined for the Isolated 
SH3 motif of a non-erythroid tz-spectrin purified after 
expression in E,:coli ndicates a high content of ,&struc- 
ture (around 70%) in agreement with this suggestion (A. 
M. and M. S., unpublished). 
Most of the conserved amino acids seem to be impor- 
tant for the secondary structure. Very few residues in 
the predicted loops are strictly conserved. The surface 
loops could be important in binding to other proteins. 
A number of mutations in the SH3 domain of Src, 
which convert it into a transforming protein, have been 
described [27,28]. These mutations include substitutions 
of both Y8 and Y IO with phenylalanines and substitu- 
tions which affect R 13 and T14. They fall into a loop 
region and could perturb a protein binding site. How- 
Fig. 2. An aligment of SH3 sequences. This aligmcnt was generated with the Genetic Data Environment colour alignlent editor (S. Smith, Harvard 
University) and the colour masking program COLORMASK (J. Thompson, EMBL) cmphasieing conscrvcd features. Symbols used for the 
consensus (bottom lines) are: %, >50% hydrophobic residues; #, ~85% hydrophobic residues; -+-, >GO% K+R: -, rGP% D+E. Capitals indicate 
residues with >85% conservation: The sequences are coloured to illustrate structurally important features, All G (orange) and P (yellow) residues 
arc coloured, Columns arc coloured by most conserved feature. For aSO% occurrence of a residue property, the matching residues are coloured 
according to the following scheme: hydrophobic = blue, hydrophobic tendency = light blue, basic = red, acidic = purple. Q or N and S or T = 
green. Columns which arc Ich white show poor conservation of residue or property, The single letter code in lower key is used for amino acids. 
The sequences were taken from the SwissProt Database (release #20). SPC-A dcnotcs a-spectrin from chicken (C) and fruh fly (Dm); M1L.B and 
-r are cyloplasmic myosins from ~c~~trlz~~!~a (AC). Human (H), mouse (M), rabbit (R), chicken, bull frog (Xl) or fruit fly (proto)oncogcnc 
products FYN, VAV, FGR, SRC, YES, NCK, GAG.CRK, LYN, WK. BLK. LSK, ABL, DLG. TEC, CSK and TKL arcofviral (v-) or cellular 
Cc- or no prefix) origin. ASV, RSV and FSV arc avian, Rous and feline sarcoma viruses, respectively. HSI is a nuclear protein; NCFI and NCFZ 
ure neulrophil cytoplasmic factors; human PLC and PLCI as well as rabbit and buvinr (13) PLC-II are phospholipnse C’s; GAP is ras-GTPase 
activating protein; P55 is a major palmitoylatcd erythrocytc membrane protein; P80/85 is a subsirate of Src kinase; P85A and B arc subunits OF 
PI-3-kinase. These, and the yeast (Y, Sp) proteins ABPI, BEM 1, CDC?S, PUS1 and STEG are discussed in the text where the refercnbrs are found. 
Multiple copies of SH3 are indicated with g/1.2,3. Residue numbering is shown on the top. Stars (*) indicate N- and C-termini. 
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ever, mutations in conserved residues may also cause 
gross structure! a!terations, which indirectly abolish 
function. 
Y8 and Y 10 are not normally phosphorylated in vivo. 
However, an activated form of Src has probably been 
found to be phosphorylated on tyrosine(s) in its N- 
terminal part [29], most likely on one or both of these 
residues. Although this suggests that YS and YlO may 
be potential sites for regulation of the SH3 function in 
Src [30], these tyrosines are not strictly invariant in SH3 
and are often substituted with phenylalanines (Fig. 2). 
The low similarity between SH3 sequences has also 
created confusion in the identification of putative SH3 
domains. For example, an SH3 domain has been rc- 
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ported in the IRA1 protein of Succ/raro/nyces cerevisiue 
(see [5]) but this sequence does not fit into our align- 
ment. The consensus sequence of Fig, 2, in conjunction 
wit11 the pattern of glycines and prolines in it, may be 
a good guide for identification and future classification 
of SH3 sequences. 
3. SH3 IN YEAST 
Four SHIcontaining proteins have been described in 
the budding yeast Succharomyces cerevisiae. Two of 
these, Bern- 1 and Abp- 1, have a role in budding [I 3-I 61. 
Fus-I is an essential factor for cell fusion during mating 
[!7,!8]. Cdc25 is a guanine nucleotide xcllangc factor, 
which is thought to regulate the Rasiadenylate cyclase 
pathway [!9]. So far, no SH2 sequences have been de- 
tected in yeast. 
In budding yeast, botll cell growth and mating are 
polarised phenomena, whicll imply definition of cell 
axis, During cell growth, microtubules and actin cables 
define an axis along whicll cellular materials are trans- 
ported towards the growing area of the membrane 
[3!,32]. In the bud, actin forms patches in the cortical 
region. Abpl, an actin-binding protein, is exclusively 
localised to tllese structures. Its function is related to 
formation of actin patches: overexpression of Abpl 
leads to formation of patches in abnormal areas such 
as the cortical region of the mother cell [IS]. The same 
phenotype is observed upon disruption of other genes, 
which Ilave been classified as ‘bud site assembly’ genes. 
These include c&24, c&42, and cdc43 and encode a 
putative calcium-binding protein, a ras-like GTP-bind- 
ing protein and a factor involved in C-terminal prenyla- 
tion of small GTP-binding proteins, respectively [3 I]. 
Small GTP-binding proteins appear also to be impor- 
tant for the localization of the bud site, The localization 
depends on the orientation of the axis in the previous 
cell division. Mutations in five genes (bud!-5) lead to a 
random budding pattern [31,33]. Bud! (also known as 
Rsr!) is a small GTP-binding protein [34]. bud5 encodes 
a guanine nucleotide xchange factor wllose catalytic 
domain is related to the catalytic domain of Cdc25. 
Genetic studies have established that Bud5 interacts 
with Bern1 [13], an SH3-containing protein, which is 
encoded by one of the ‘bud site assembly’ genes. The 
localization of budding site is a signal for a class of 
proteins produced by these genes. Their function is to 
Iimi! surface growth to this area. Bud site assembly 
imiolves a specific organization of actin and tubulin 
both in the motller cell and in the bud. This organiza- 
tion is thought to drive organelle transport o the site 
of assembly, and in this way promote surface growtll 
[3 I]. Interplay between bud-site-assembly gene products 
and cytoskeletal elements is necessary for polarising 
yeast cells. 
It would be interesting to know if any SH3-containing 
proteins have a comparable function in development of 
cell polarity in higher eukaryotes. Woods and Bryant 
[22] have recently shown that the product of the dgl 
tumor suppressor gene in Drosophikt, an SH3-contain- 
ing protein which is localized at scptate junctions, is 
involved in development of apical-basal polarity in cells 
of imagina! discs. Dgl is homologous to a 55 kDa SH3- 
containing protein of the erythrocyte membrane. Botll 
proteins have a domain homologous to the yeast 
guanylate kinase suggesting that Dgl and p55 may have 
guanylate kinase activity [35]. 
4. SH3 1N SIGNAL TRANSDUCTION 
PDGFR and epidermal growth factor receptor 
(EGFR) belong to a family of trnnsmembrane r cep- 
tors, whose cytoplasmic moiety has intrinsic tyrosine 
kinase activity [36,37]. Many details of the molecular 
mecllanisms by which signal transduction through these 
receptors takes place, have been elucidated in recent 
years. Upon induction with PDGF, for example, anum- 
ber of proteins whicll include Src (or a src-related ki- 
nase), PLCy, PI-3-kinase and GAP, become physically 
associated with the activated receptor (see [S]). 
SH2 is a noncatalytic domain common to many sub- 
strates of the activated receptors, and may play an es- 
sential role in the formation of the transducing complex. 
Upon induction with the appropriate growth factor, 
receptors of the tyrosine kinase family are thougllt to 
dimerise and autop!~osp!zory!ate on tyrosine residues. 
SH2 domains recognize, and bind to, phosphorylated 
tyrosine residues whick are within a specific amino acid 
sequence. Phosphotyrosinc residues constitute the sig- 
nal which promotes association of a number of sig- 
nailing proteins via tlleir SH2 domains to the receptor 
[38-40]. These proteins are then phosphorylated by ty- 
rosine kinase activity of the receptor. The association to 
the receptors is important for activation of the intracel- 
lular steps in signal transduction, wllich lead to changes 
in gene expression, cellular metabolism, and cytoskel- 
eta! architecture [41]. 
In contrast, the role of SH3 in signal transduction 
remains unclear. Most of the available information 
comes from the analysis of mutations in the SH3 do- 
mains of different signalling proteins. Several mutations 
of Src, which cause morphological alterations and cellu- 
lar transformation due to uncontrolled kinase activity, 
Irave been isolated (e.g. [25,42]). Some of these muta- 
tions are in the catalytic domain, whereas others map 
into the non-catalytic regions, including the SH3 do- 
main, Deletions of the SH3 domain in Src also cause’ 
cellular transformation. Similarly, Jackson and Balti- 
more [43] have reported that deletions in the SH3 do- 
main of the c-Ab! cytoplasmic tyrosine kinase induce a 
transformed phenotype when tlley are introduced into 
fibroblasts. 
It is widely accepted that abnormal tyrosine phospho- 
rylation caused by these mutations leads to cellular 
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transformation [27,28,42], but mechanisms by which 
this could happen have not been fully elucidated. In any 
case, these observations uggest hat SH3 may be in- 
volvcd in down-regulation of the Src tyrosine kinase 
activity [27&l]. One can imagine at least hree ways by 
which SH3 deletions or mutations may lead to a failure 
to regulate the kinase activity. First, SH3 may inhibit 
the kinasc activity through an intramolecular mecha- 
nism, for example by binding to the kinase domain. In 
this case, deletion of SH3 may cause increased phosphc- 
rylation of normal substrates as well as phasphoryla- 
tion of new, abnormal substrates. The current model is, 
however, that SH2 is the main intramolecular regulator 
of the Src kinase activity [45]. And it is evident hat the 
sole function of SH3 cannot be the intramolecular regu- 
lation of kinase activity, because it is present in proteins 
that have no catalytic kinase domain (Fig. 1). 
Secondly, SH3 may bind to another molecule which 
is able to switch the kinase activity on and off in re- 
sponse to appropriate stimuli. Small GTP-binding pro- 
teins could have such a function. They are apparently 
able to regulate other proteins’ activity through confor- 
mational rearrangments [SG]. 
The third possibility is that an SH3 deletion may 
impair the abiliLy of kinase to choose right substrates, 
which would lead to phosphorylation of wrong ones. A 
consequence of such a model is that it should be possible 
to see changes in the pattern of proteins phosphorylated 
by Src after deleting SH3. Brugge and coworkers [42] 
have recently shown that deletions in the SH3 domain 
of Src lead to an increase in tyrosine phosphorylation. 
However, the phosphorylation pattern of cellular pro- 
teins by the transforming forms of Src with an intact 
SH3 domain is similar to the one observed after deletion 
of SH3. This suggests that SH3 does not regulate cata- 
lytic activity of Src via substrate recognition but via a 
more direct effect on the kinase activity itself. As 
pointed out, this may occur either through an intramol- 
ecular mechanism or through interaction whh an.other 
regulatory protein. In the latter case, mutations in a 
gene encoding such a regulatory protein would also 
cause celiular transformation [43]. 
Development of experimental approaches which 
combine genetics an d biochemical techniques give some 
hope in unravelling the impressively complex network 
of interactions between signalling, cytoskeletal, and reg- 
ulatory proteins in signalling pathways. Organisms like 
Drosopltiku and C. elegans seem to be ideal systems fol 
such experiments. 
Recently, Clark and coworkers [23] have shown that 
mutations in both SH3-coding regions of the se/rnS gene 
can affect vulva1 development and sex myoblast migra- 
tion during development of C.. &guns. The product of 
se/t25 is a 228 amino acid protein, which contains only 
two SH3 and one SH2 domain with no evident catalytic 
domain (Fig. 1). In the latter respect mammalian pro- 
teins such as the pS5 subunit of PI-3-kinase, Nck, v-Crk, 
and c-Crk are comparable to Sem5, and also involved 
in signal transduction [5]. The lack of catalytic activity 
suggests that these proteins may act as adaptors, creat- 
ing a link between phosphotyrosine containing proteins 
(via SH2) and specific lasses of substrates or regulatory 
proteins (via SH3 [47]). Two other genes are known to 
control signal transduction in vulva1 cells of C. rlegu/~ 
The product of the let23 gene is a transmembrane tyro- 
sine kinase homologous to the EGFR, and Let60 is a 
ras-like GTP-binding protein. Genetic experiments in- 
dicate that Sem5 and Let23 act before Let60 in vulva1 
induction. It is possible that the SH2 domain of Sem5 
promotes binding to phosphotyrosine residues on the 
Let23 protein, which leads to activation of the l&O 
gene product [23]. In this case, SH3 could have the 
important function of selecting atarget - maybe a GDP 
exchange factor -which is able to influence the activity 
of Let60 protein. Mutations in both SH3 domains of 
Sem5 have a deleterious effect on its function. This 
suggests that these two domains are functionally not 
redundant. Hopefully, further genetic analysis will lead 
to identification of the functions involved in this sig- 
nailing process downstream of Sem5 activity (see 
[23,47]). 
5. CONCLUSIONS AND HYPOTHESES 
The long evolutionary history of SH3 and its presence 
in diverse proteins must reflect he fact that SH3 carries 
out a vital function in different cellular processes. The 
molecular mechanisms through which this domain acts, 
have not yet been elucidated. The most urgent problem 
is to identify proteins that bind to SH3 with high afin- 
ity. The fact that SM3 can regulate the activity of differ- 
ent protein tyrosine kinases makes this objective partic- 
ularly interesting. Such studies might lead to identifica- 
tion of other proteins involved in the control of cell 
differentiation and proliferation. 
Sequence analysis (Fig. 2) shows that SH3 has prob- 
ably a ,&sheeL structure. Localization of possible bind- 
ing sites for protein targets is complicated by the lack 
of extensive homology among different SH3 scrjuences. 
This evolutionary divergence becomes meaningful, if 
the proteins that. bind to SH3 are also divergent but 
evolutionarily related. Some hypotheses have been 
made on the SH3 target. None of them seems to be 
conclusive. As most of the SH3-containing proteins are 
localised to the cortical region of the cell, actin has been 
indicated as a potential target. Moreover, some proteins 
which are known to bind actin, contain an SH3 domain. 
These include Abpl, cytoplasmic myosiris in amoeban 
cells, and spectrin. The structures of the Abpl protein 
and unconventional moeban myosins are quite similar 
[46]. Their SI-13 domains are located at the C-terminus, 
and similarity in their amino acid sequences extends 
towards the N-termini [16]. A 30 kDa C-terminal frag- 
ment of Acunr/rurnoebu myosin-I contains an ATP-inde- 
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is, in contrast, in the middle of the a-chain 
while its (main) a&n-binding domain is at the N-termi- 
nus of the /?-chain [7,SO]. Other proteins, like ezrin and 
calpactin, have been i dicated as possible ligands of the 
specirin SH3 [16,51]. Calpactin is a potential substrate 
of Src, and moreover colocalised with spectrin [16,52]. 
Jackson and Baltimore [43] have included G-proteins 
as possible targets of the SH3 domain in the Abl tyro- 
sine kinase. This hypothesis is intriguing, because it 
postulates the existance of a network of interactions 
among apparently separate signal transduction path- 
ways. The localization of many G-proteins at the 
plasma membrane also makes this hypothesis coherent 
from a topological point of view. 
The possibility that SH3 domains in diverse proteins 
bind to different small GTP-binding proteins is interest- 
ing. Small GiP-binding proteins take part in different 
celiular processes such as protein transport and sorting, 
cell differentiation and proliferation, organization of 
cytoskeleton and protein synthesis [46]. This functional 
diversity would match with the presence of SH3 do- 
mains in cytoskeletal nd signalling proteins as well as 
in proteins involved in cell polarization. The p47 and 
~67 cytosolic omponents of the human neutrophil res- 
piratory burst oxidase have been partially purified using 
GTP-agarose. This observation suggests that complexes 
are formed between these proteins, which both contain 
a SH3 domain, and (unidentified) GTP-binding pro- 
teins [53,54]. 
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